Institute of Medicine (US) Committee to Design a Strategy for Quality Review and Assurance in Medicare. Chapter 5, Defining quality of care. In: Medicare: a strategy for quality assurance, vol. II. Sources and methods. Washington, DC: National Academies Press (US); 1990.
Institute of Medicine Committee on Quality of Health Care in A. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press (US) . Copyright 2001 by the National Academy of Sciences. All rights reserved.; 2001.
Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44(3 Suppl):166–206.
Branch-Elliman W, O’Brien W, Strymish J, Itani K, Wyatt C, Gupta K. Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events. JAMA Surg. 2019;154(7):590–8.
Coster WJ. Making the best match: selecting outcome measures for clinical trials and outcome studies. Am J Occup Ther. 2013;67(2):162–70.
Lane-Fall MB, Neuman MD. Outcomes measures and risk adjustment. Int Anesthesiol Clin. 2013;51(4):10–21.
Kutlu OC, Lee JE, Katz MH, Tzeng CD, Wolff RA, Varadhachary GR, et al. Open pancreaticoduodenectomy case volume predicts outcome of laparoscopic approach: a population-based analysis. Ann Surg. 2018;267(3):552–60.
Gooiker GA, van Gijn W, Wouters MW, Post PN, van de Velde CJ, Tollenaar RA. Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br J Surg. 2011;98(4):485–94.
Urbach DR. Pledging to eliminate low-volume surgery. N Engl J Med. 2015;373(15):1388–90.
Torgeson A, Garrido-Laguna I, Tao R, Cannon GM, Scaife CL, Lloyd S. Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins. ESMO Open. 2018;3(1):e000282.
Apollos JR, Sami S, Prasanth MN, Jeyakumar J, McFadyen AK. Pre-diagnostic delays caused by gastrointestinal investigations do not affect outcomes in pancreatic cancer. Ann Med Surg. 2018;34:66–70.
Martin HL, Ohara K, Chin W, Davidson A, Bayliss E, Redfern A, et al. Cancer services in Western Australia: a comparison of regional outcomes with metropolitan Perth. Aust J Rural Health. 2015;23(5):302–8.
Burmeister EA, O’Connell DL, Jordan SJ, Goldstein D, Merrett N, Wyld DK, et al. Factors associated with quality of care for patients with pancreatic cancer in Australia. Med J Aust. 2016;205(10):459–65.
Gill AJ, Johns AL, Eckstein R, Samra JS, Kaufman A, Chang DK, et al. Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology. 2009;41(2):161–7.
Prades J, Remue E, van Hoof E, Borras JM. Is it worth reorganising cancer services on the basis of multidisciplinary teams (MDTs)? A systematic review of the objectives and organisation of MDTs and their impact on patient outcomes. Health Policy. 2015;119(4):464–74.
Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003;15(6):523–30.
Prosser-Snelling E, Morris E. Quality indicators. Obstetr Gynaecol Reprod Med. 2017;27(9):290–2.
Deming WE. Out of the crisis. Cambridge, MA: MIT Press; 2000.
Taylor MJ, McNicholas C, Nicolay C, Darzi A, Bell D, Reed JE. Systematic review of the application of the plan–do–study–act method to improve quality in healthcare. BMJ Qual Saf. 2014;23(4):290.
Dalkey NC. The Delphi method: an experimental study of group opinion. Santa Monica, CA: RAND Corp; 1969.
Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR. The RAND/UCLA appropriateness method user’s manual. Santa Monica, CA: RAND Corp; 2001.
Bilimoria KY, Bentrem DJ, Lillemoe KD, Talamonti MS, Ko CY, On behalf of the American College of Surgeons’ Pancreatic Cancer Quality Indicator Development Expert P. Assessment of pancreatic cancer care in the United States based on formally developed quality indicators. J Natl Cancer Inst. 2009;101(12):848–59.
Burmeister EA, Jordan SJ, O’Connell DL, Beesley VL, Goldstein D, Gooden HM, et al. Using a Delphi process to determine optimal care for patients with pancreatic cancer. Asia Pac J Clin Oncol. 2016;12(2):105–14.
Maharaj AD, Ioannou L, Croagh D, Zalcberg J, Neale RE, Goldstein D, et al. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. HPB (Oxford). 2019;21(4):444–55.
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
Corbellini C, Andreoni B, Ansaloni L, Sgroi G, Martinotti M, Scandroglio I, et al. Reliability and validity assessment of administrative databases in measuring the quality of rectal cancer management. Tumori J. 2018;104(1):51–9.
Lordick F, On behalf of the EGC, Mariette C, On behalf of the EGC, Haustermans K, On behalf of the EGC, et al. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2016;27(Suppl 5):v50–7.
Porter ME, Kaplan RS, Frigo ML. Managing healthcare costs and value. Strategic Finance. 2017;98(7):24.
Porter ME. What is value in health care? N Engl J Med. 2010;363(26):2477–81.
Gerritsen A, Jacobs M, Henselmans I, van Hattum J, Efficace F, Creemers G-J, et al. Developing a core set of patient-reported outcomes in pancreatic cancer: a Delphi survey. Eur J Cancer. 2016;57:68–77.
Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10–27.
Beesley VL, Janda M, Goldstein D, Gooden H, Merrett ND, O’Connell DL, et al. A tsunami of unmet needs: pancreatic and ampullary cancer patients’ supportive care needs and use of community and allied health services. Psychooncology. 2016;25(2):150–7.
Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012;21(8):1305–14.
Maharaj AD, Samoborec S, Evans SM, Zalcberg J, Neale RE, Goldstein D, Merrett N, White K, Croagh D, Pilgrim CHC, Evans P, Knowles B, Leong T, Philip J, Smith M, Ioannou L. Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review. HPB (Oxford). 2019;22(2):187–203.
Wilcox N, McNeil JJ. Clinical quality registries have the potential to drive improvements in the appropriateness of care. Med J Aust. 2016;205(S10):S21–S6.
Sherman S, Shats O, Ketcham MA, Anderson MA, Whitcomb DC, Lynch HT, et al. PCCR: pancreatic cancer collaborative registry. Cancer Informat. 2011;10:83–91.
Fristrup C, Detlefsen S, Hansen CP, Ladekarl M. Danish pancreatic cancer database. Clin Epidemiol. 2016;8:645–8.
Maharaj AD, Holland JF, Scarborough R, Evans SM, Ioannou L, Brown WA, Croagh D, Pilgrim CHC, Kench JG, Lipton LR, Leong T, McNeil JJ, Nikfarjam M, Aly A, Burton PR, Cashin PA, Chu J, Duong C, Evans P, Goldstein D, Haydon A, Hii MW, Knowles BPF, Merrett N, Michael M, Neale RE, Philip J, Porter IWT, Smith M, Spillane J, Tagkalidis PP, Zalcberg J. Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers. BMJ Open. 2019;9(9):e031434.
Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;(6):CD000259.